Doctorpresso to Launch AI-Powered Group Therapy Earbuds at CES 2026
Doctorpresso's Therapods earbuds use advanced AI and biosensing technology to deliver virtual group therapy at reduced costs, potentially transforming access to mental healthcare by addressing traditional barriers of cost, stigma, and limited availability.
Doctorpresso, a leading AI mental health technology company, will unveil Therapods at CES 2026 in Las Vegas, introducing what the company describes as the world's first AI-powered earbuds for virtual group therapy. The device delivers real-time emotion sensing and group interaction analysis at a fraction of traditional therapy costs, potentially revolutionizing how mental healthcare is accessed and delivered globally.
Therapods integrate advanced AI and multimodal biosensing to track voice patterns, brainwaves, and heart rate variability, delivering real-time emotional insights with more than 90% accuracy. By restoring critical nonverbal cues often lost in remote therapy, the device addresses one of the biggest challenges in virtual mental healthcare. This technological advancement comes at a critical time when the global mental health system continues to face significant challenges, with traditional barriers including cost, stigma, and limited access leaving wide gaps in care.
The technology has received notable industry validation, earning a finalist position for the 2025 GLOMO Awards at Mobile World Congress. At CES 2026, attendees will experience firsthand demonstrations of Therapods' emotion-sensing and virtual group therapy applications, highlighting its potential to reshape digital mental healthcare. The company's work has been recognized across the industry, with achievements ranging from peer-reviewed studies to global award nominations, establishing Doctorpresso as a leader in digital mental health innovation.
Doctorpresso is exploring partnerships with corporations, telemedicine providers, and educational institutions to broaden Therapods' reach. The company's long-term vision is to establish a preventive mental health ecosystem where emotional wellbeing becomes a seamless part of everyday life. At CES 2026, Doctorpresso will announce new collaborations and showcase how Therapods technology can be adopted across industries, reinforcing its position as a global leader in AI-powered healthcare innovation. The company develops AI wearables supported by multiple patents and clinical validations, combining rigorous scientific validation with intuitive design to ensure both therapeutic impact and user trust.
Therapods aim to bridge care gaps by offering a scalable solution that delivers personalized emotional insights while maintaining clinical-grade security and privacy standards. Hwanbo Jung, CEO of Doctorpresso, stated that Therapods represent a major leap in accessible mental health technology. By merging advanced AI with human-centered design, the company aims to break down traditional barriers and bring proactive emotional support to people everywhere, potentially transforming how mental healthcare is delivered on a global scale.